Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of respiratory depression of remimazolam vs propofol for sedation in painful procedure
KCT0009046Phase 4Not yet recruiting
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in pain (2 arms), sponsored by Seoul St. Mary's Hospital. Primary endpoint: Respiratory depression comparison. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
pain
Beyond the preview
Go deeper on KCT0009046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009046.